Show simple item record

dc.contributor.authorChacon, Rafael
dc.contributor.authorMirza, Sara
dc.contributor.authorRodriguez, David
dc.contributor.authorParedes, Antonio
dc.contributor.authorGuzman, Giselle
dc.contributor.authorMoreno, Lourdes
dc.contributor.authorThen, Cecilia J
dc.contributor.authorJara, Jorge
dc.contributor.authorBlanco, Natalia
dc.contributor.authorBonilla, Luis
dc.contributor.authorClara, Wilfrido A
dc.contributor.authorMinaya, Percy
dc.contributor.authorPalekar, Rakhee
dc.contributor.authorAzziz-Baumgartner, Eduardo
dc.date.accessioned2015-09-01T18:41:45Z
dc.date.available2015-09-01T18:41:45Z
dc.date.issued2015-07-31
dc.identifier.citationBMC Public Health. 2015 Jul 31;15(1):734
dc.identifier.urihttp://dx.doi.org/10.1186/s12889-015-2064-z
dc.identifier.urihttp://hdl.handle.net/10724/32049
dc.description.abstractAbstract Background The demographic characteristics of pandemic influenza decedents among middle and low-income tropical countries are poorly understood. We explored the demographics of persons who died with influenza A (H1N1)pdm09 infection during 2009–2010, in seven countries in the American tropics. Methods We used hospital-based surveillance to identify laboratory-confirmed influenza deaths in Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and Dominican Republic. An influenza death was defined as a person who died within two weeks of a severe acute respiratory infection (SARI) defined as sudden onset of fever >38 °C, cough or sore-throat, and shortness of breath, or difficulty breathing requiring hospitalization, and who tested positive for influenza A (H1N1)pdm09 virus by real time polymerase chain reaction. We abstracted the demographic and clinical characteristics of the deceased from their medical records. Results During May 2009-June 2010, we identified 183 influenza deaths. Their median age was 32 years (IQR 18–46 years). One-hundred and one (55 %) were female of which 20 (20 %) were pregnant and 7 (7 %) were in postpartum. One-hundred and twelve decedents (61 %) had pre-existing medical conditions, (15 % had obesity, 13 % diabetes, 11 % asthma, 8 % metabolic disorders, 5 % chronic obstructive pulmonary disease, and 10 % neurological disorders). 65 % received oseltamivir but only 5 % received it within 48 h of symptoms onset. Conclusions The pandemic killed young adults, pregnant women and those with pre-existing medical conditions. Most sought care too late to fully benefit from oseltamivir. We recommend countries review antiviral treatment policies for people at high risk of developing complications.
dc.titleDemographic and clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in Central America and Dominican Republic 2009–2010
dc.typeJournal Article
dc.date.updated2015-07-31T03:45:55Z
dc.language.rfc3066en
dc.rights.holderChacón et al.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record